4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Summarizes the competitive environment, macro signals, and segment-level movements driving market outcomes.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITION RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS AND FORECAST
5.2.2
TRENDS IN NORTH AMERICA EPIGENETICS MARKET
5.2.3
TRENDS IN NORTH AMERICA GENOMICS INDUSTRY
5.4.1
EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS
5.5.1
AVERAGE SELLING PRICE TREND OF EPIGENETICS, BY PRODUCT, 2022–2024
5.5.2
AVERAGE SELLING PRICE TREND OF EPIGENETICS, BY COUNTRY, 2022–2024
5.6
TRADE ANALYSIS, 2020–2024
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF ON NORTH AMERICA EPIGENETICS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES/REGIONS
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.1
SINGLE-CELL SEQUENCING
6.1.2
CHROMATIN IMMUNOPRECIPITATION
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
DNA METHYLATION MICROARRAYS
6.2.2
CRISPR-BASED GENOME EDITING
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON NORTH AMERICA EPIGENETICS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN NORTH AMERICA EPIGENETICS MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NORTH AMERICA EPIGENETICS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
NORTH AMERICA EPIGENETICS MARKET, BY OFFERING, (MARKET SIZE 2023 – 2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY OFFERINGS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.2.3
INSTRUMENTS & ACCESSORIES
10
NORTH AMERICA EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH APPLICATION
10.3
HISTONE MODIFICATION
11
NORTH AMERICA EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
12
NORTH AMERICA EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
12.5
DEVELOPMENTAL BIOLOGY
12.6
CARDIOVASCULAR DISEASES
13
NORTH AMERICA EPIGENETICS PRODUCS MARKET, BY END USER, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
13.2
ACADEMIC & RESEARCH INSTITUTES
13.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5
CONTRACT RESEARCH ORGANIZATIONS
14
NORTH AMERICA EPIGENETICS PRODUCS MARKET, BY END USER, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
14.2
ACADEMIC & RESEARCH INSTITUTES
14.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
15
NORTH AMERICA EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY NORTH AMERICA REGION AND ITS COUNTRIES
15.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
16.3
REVENUE ANALYSIS, 2022-2024
16.4
MARKET SHARE ANALYSIS,
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.5.5.1
COMPANY FOOTPRINT
16.5.5.2
REGION FOOTPRINT
16.5.5.3
OFFERING FOOTPRINT
16.5.5.4
METHOD FOOTPRINT
16.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
16.6.1
PROGRESSIVE COMPANIES
16.6.2
RESPONSIVE COMPANIES
16.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
16.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
16.8
COMPANY VALUATION AND FINANCIAL METRICS
16.9
COMPETITIVE SCENARIO
16.9.1
PRODUCT/SERVICE LAUNCHES
16.9.3
OTHER DEVELOPMENTS
17.1.1
THERMO FISHER SCIENTIFIC INC.
17.1.6
BIO-RAD LABORATORIES, INC.
17.1.8
NEW ENGLAND BIOLABS
18.1.1.1
KEY SOURCES OF SECONDARY DATA
18.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
18.1.2.1
BREAKDOWN OF PRIMARIES
18.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
18.2
MARKET SIZE ESTIMATION
18.2.1
NORTH AMERICA EPIGENETICS MARKET SIZE ESTIMATION
18.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
18.2.1.2
MNM REPOSITORY ANALYSIS
18.2.1.3
SECONDARY ANALYSIS
18.2.1.4
PRIMARY RESEARCH
18.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
18.2.2
SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
18.3
MARKET GROWTH RATE PROJECTIONS
18.6
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in North America Epigenetics Market